{
  "actions": [
    {
      "acted_at": "2015-02-05", 
      "action_code": "Intro-H", 
      "references": [], 
      "text": "Introduced in House", 
      "type": "action"
    }, 
    {
      "acted_at": "2015-02-05", 
      "action_code": "H11100", 
      "committees": [
        "HSIF"
      ], 
      "references": [], 
      "status": "REFERRED", 
      "text": "Referred to the House Committee on Energy and Commerce.", 
      "type": "referral"
    }, 
    {
      "acted_at": "2015-02-06", 
      "action_code": "", 
      "committees": [
        "HSIF"
      ], 
      "references": [], 
      "text": "Referred to the Subcommittee on Health.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "hres95-114", 
  "bill_type": "hres", 
  "by_request": false, 
  "committees": [
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF"
    }, 
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF", 
      "subcommittee": "Subcommittee on Health", 
      "subcommittee_id": "14"
    }
  ], 
  "congress": "114", 
  "cosponsors": [
    {
      "bioguide_id": "H001034", 
      "district": "17", 
      "name": "Honda, Michael M.", 
      "original_cosponsor": false, 
      "sponsored_at": "2015-04-23", 
      "state": "CA", 
      "thomas_id": "01634", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "bioguide_id": "P000608", 
      "district": "52", 
      "name": "Peters, Scott H.", 
      "original_cosponsor": false, 
      "sponsored_at": "2015-04-23", 
      "state": "CA", 
      "thomas_id": "02113", 
      "title": "Rep", 
      "withdrawn_at": null
    }
  ], 
  "enacted_as": null, 
  "history": {
    "active": false, 
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2015-02-05", 
  "number": "95", 
  "official_title": "Recognizing the importance of transformative breakthroughs in biomedicine, biotechnology, and life sciences in the diagnosis, management, curing, and treatment of illness and the existence of a \"Valley of Death\" in biotechnology and life sciences funding that stifles innovation and impedes translational medical research.", 
  "popular_title": null, 
  "related_bills": [], 
  "short_title": null, 
  "sponsor": {
    "bioguide_id": "V000130", 
    "district": "51", 
    "name": "Vargas, Juan", 
    "state": "CA", 
    "thomas_id": "02112", 
    "title": "Rep", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2015-02-05", 
  "subjects": [
    "Advanced technology and technological innovations", 
    "Biological and life sciences", 
    "Department of Health and Human Services", 
    "Drug safety, medical device, and laboratory regulation", 
    "Executive agency funding and structure", 
    "Food and Drug Administration (FDA)", 
    "Health", 
    "Health programs administration and funding", 
    "Health technology, devices, supplies", 
    "Medical research", 
    "Research administration and funding", 
    "Research and development"
  ], 
  "subjects_top_term": "Health", 
  "summary": {
    "as": "Introduced in House", 
    "date": "2015-02-05T05:00:00Z", 
    "text": "Recognizes: the value of biomedicine, biotechnology, and life sciences; the challenges those industries face; and the ways those challenges can be addressed."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Recognizing the importance of transformative breakthroughs in biomedicine, biotechnology, and life sciences in the diagnosis, management, curing, and treatment of illness and the existence of a \"Valley of Death\" in biotechnology and life sciences funding that stifles innovation and impedes translational medical research.", 
      "type": "official"
    }, 
    {
      "as": null, 
      "is_for_portion": false, 
      "title": "Recognizing the importance of transformative breakthroughs in biomedicine, biotechnology, and life sciences in the diagnosis, management, curing, and treatment of illness and the existence of a \"Valley of Death\" in biotechnology and life sciences funding that stifles innovation and impedes translational medical research.", 
      "type": "display"
    }
  ], 
  "updated_at": "2016-08-01T13:25:31Z", 
  "url": "https://www.gpo.gov/fdsys/bulkdata/BILLSTATUS/114/hres/BILLSTATUS-114hres95.xml"
}